Multicenter Phase II Study of a New Effective S-1 and Irinotecan Combination Schedule in Patients with Unresectable Metastatic or Recurrent Colorectal Cancer

Multicenter Phase II Study of a New Effective S-1 and Irinotecan Combination Schedule in Patients with Unresectable Metastatic or Recurrent Colorectal Cancer

Bibliographic Details
Main Authors: Yutaka Ogata, Takaho Tanaka, Yoshito Akagi, Nobuya Ishibashi, Yoshiaki Tsuji, Keiko Matono, Makoto Isobe, Susumu Sueyoshi, Atsushi Kaibara, Kazuo Shirouzu
Format: Article
Language:English
Published: SAGE Publishing 2013-02-01
Series:Clinical Medicine Insights: Oncology
Online Access:http://la-press.com/multicenter-phase-ii-study-of-a-new-effective-s-1-and-irinotecan-combi-article-a3528

Internet

http://la-press.com/multicenter-phase-ii-study-of-a-new-effective-s-1-and-irinotecan-combi-article-a3528

Similar Items